サンプル依頼リスト カート
  • English
  • Korean
デフォルト表紙
市場調査レポート
商品コード
1417529

乳房病変局在化市場レポート：2030年までの動向、予測、競合分析

Breast Lesion Localization Market Report: Trends, Forecast and Competitive Analysis to 2030
出版日: | 発行: Lucintel | ページ情報: 英文 150 - page report | 納期: 3営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報（例：国別セグメント）の追加などの対応が可能です。　 詳細はお問い合わせください。

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=157.14円

ご注意:　DRM (デジタル著作権管理システム) 付PDFになります。
制限内容は、上記ライセンスの[詳細]アイコンをクリックしてご確認ください。

乳房病変局在化市場レポート：2030年までの動向、予測、競合分析
出版日: 2024年01月29日
発行: Lucintel
ページ情報: 英文 150 - page report
納期: 3営業日
ご注意事項 :
本レポートは最新情報反映のため適宜更新し、内容構成変更を行う場合があります。ご検討の際はお問い合わせください。
  • 全表示
  • 概要
  • 目次
概要

乳房病変局在化の動向と予測

世界の乳房病変局在化市場は、2024年から2030年までのCAGRが7.1％で、2030年までに推定4億5,300万米ドルに達すると予測されます。この市場の主な促進要因は、乳がんの早期発見に関する知識の増加、乳がん手術件数の増加、正確で低侵襲な手術に対するニーズの高まりです。世界の乳房病変局在化市場の将来は、病院・診療所、画像診断センター、外来手術センター市場における機会で有望視されています。

乳房病変局在化市場の洞察

Lucintelの予測では、早期乳がんの発見が増加し、侵襲性の低い方法への移行が進んでいることから、乳房温存療法が予測期間中に高い成長を遂げる見込みです。

アジア太平洋は、病院数の増加、ヘルスケア支出の増加、患者数の大幅な増加、ヘルスケアサービスに対するニーズの高まりにより、予測期間中に最も高い成長が見込まれています。

よくある質問

Q1.市場規模は？

A1.世界の乳房病変局所化市場は、2030年までに推定4億5,300万米ドルに達すると予想されています。

Q2.市場の成長予測は？

A2.世界の乳房病変局所化市場は、2024年から2030年にかけてCAGR 7.1％で成長すると予測されます。

Q3.市場の成長に影響を与える主な促進要因は？

A3.この市場の主な促進要因は、乳がんの早期発見に関する知識の増加、乳がん手術件数の増加、正確で低侵襲な手術に対するニーズの高まりです。

Q4.市場の主要セグメントは？

A4.世界の乳房病変局在化市場の将来は、病院・診療所、画像診断センター、外来手術センター市場での機会が有望です。

Q5.市場の主要企業は？

A5.乳房病変局在化の主要企業は以下の通りです。

  • GE Healthcare
  • Dragerwerk
  • Koninklijke Philips
  • Ambu AS
  • Medline Industrie

Q6.今後、最大となる市場セグメントは？

A6.Lucintelの予測では、早期乳がんの発見が増加し、侵襲性の低い方法への移行が進んでいるため、乳房温存が予測期間中に高い成長を遂げる見込みです。

Q7.市場において、今後5年間に最大になると予想される地域は？

A7.アジア太平洋は、病院数の増加とヘルスケア支出の増加、患者数の大幅な増加、ヘルスケアサービスに対するニーズにより、予測期間中に最も高い成長を示すと予想されます。

Q8.レポートのカスタマイズは可能？

A8.はい、Lucintelは追加費用なしで10%のカスタマイズを提供します。

目次

第1章 エグゼクティブサマリー

第2章 世界の乳房病変局在化市場：市場力学

  • イントロダクション、背景、分類
  • サプライチェーン
  • 業界の促進要因と課題

第3章 2018年から2030年までの市場動向と予測分析

  • マクロ経済動向（2018～2023年）と予測（2024～2030年）
  • 世界の乳房病変局在化市場の動向（2018～2023年）と予測（2024～2030年）
  • 種類別の世界の乳房病変局在化市場
    • ワイヤー限局
    • ラジオアイソトープ限局
    • 磁気限局
    • 電磁限局
    • その他
  • 用途別の世界の乳房病変局在化市場
    • 乳房生検
    • 乳房温存
  • 最終用途別の世界の乳房病変局在化市場
    • 病院とクリニック
    • 画像診断センター
    • 外来手術センター
    • その他

第4章 2018年から2030年までの地域別の市場動向と予測分析

  • 地域別の世界の乳房病変局在化市場
  • 北米の乳房病変局在化市場
  • 欧州の乳房病変局在化市場
  • アジア太平洋の乳房病変局在化市場
  • その他地域の乳房病変局在化市場

第5章 競合の分析

  • 製品ポートフォリオ分析
  • 運用上の統合
  • ポーターのファイブフォース分析

第6章 成長機会と戦略的分析

  • 成長機会分析
    • タイプ別の世界の乳房病変局在化市場の成長機会
    • 用途別の世界の乳房病変局在化市場の成長機会
    • 最終用途別の世界の乳房病変局在化市場の成長機会
    • 地域別の世界の乳房病変局在化市場の成長機会
  • 世界の乳房病変局在化市場における新たな動向
  • 戦略的分析
    • 新製品の開発
    • 世界の乳房病変局在化市場の能力拡大
    • 世界の乳房病変局在化市場における合併、買収、合弁事業
    • 認証とライセンシング

第7章 有力企業の企業プロファイル

  • GE Healthcare
  • Dragerwerk
  • Koninklijke Philips
  • Ambu AS
  • Medline Industrie
目次

Breast Lesion Localization Trends and Forecast

The future of the global breast lesion localization market looks promising with opportunities in the hospital & clinic, diagnostic imaging center, and ambulatory surgical center markets. The global breast lesion localization market is expected to reach an estimated $453 million by 2030 with a CAGR of 7.1% from 2024 to 2030. The major drivers for this market are increased knowledge of early breast cancer detection, rise in the number of breast cancer surgeries, as well as, growing need for accurate and minimally invasive surgeries.

A more than 150-page report is developed to help in your business decisions.

Breast Lesion Localization by Segment

The study includes a forecast for the global breast lesion localization by type, usage, end use, and region.

Breast Lesion Localization Market by Type [Shipment Analysis by Value from 2018 to 2030]:

  • Wire Localization
  • Radioisotope Localization
  • Magnetic Localization
  • Electromagnetic Localization
  • Others

Breast Lesion Localization Market by Usage [Shipment Analysis by Value from 2018 to 2030]:

  • Breast Biopsy
  • Breast Conservation

Breast Lesion Localization Market by End Use [Shipment Analysis by Value from 2018 to 2030]:

  • Hospitals & Clinics
  • Diagnostic Imaging Centers
  • Ambulatory Surgical Centers
  • Others

Breast Lesion Localization Market by Region [Shipment Analysis by Value from 2018 to 2030]:

  • North America
  • Europe
  • Asia Pacific
  • The Rest of the World

List of Breast Lesion Localization Companies

Companies in the market compete on the basis of product quality offered. Major players in this market focus on expanding their manufacturing facilities, R&D investments, infrastructural development, and leverage integration opportunities across the value chain. With these strategies breast lesion localization companies cater increasing demand, ensure competitive effectiveness, develop innovative products & technologies, reduce production costs, and expand their customer base. Some of the breast lesion localization companies profiled in this report include-

  • GE Healthcare
  • Dragerwerk
  • Koninklijke Philips
  • Ambu AS
  • Medline Industrie

Breast Lesion Localization Market Insights

Lucintel forecasts that breast conservation is expected to witness the higher growth over the forecast period due to the increased detection of early-stage breast cancer and the trend toward less invasive methods.

APAC is expected to witness highest growth over the forecast period due to growing number of hospitals and rising healthcare expenditure, a large increase in patient volume, and a need for healthcare services.

Features of the Global Breast Lesion Localization Market

Market Size Estimates: Breast lesion localization market size estimation in terms of value ($M).

Trend and Forecast Analysis: Market trends (2018 to 2023) and forecast (2024 to 2030) by various segments and regions.

Segmentation Analysis: Breast lesion localization market size by type, usage, end use, and region in terms of value ($M).

Regional Analysis: Breast lesion localization market breakdown by North America, Europe, Asia Pacific, and Rest of the World.

Growth Opportunities: Analysis of growth opportunities in different type, usage, end use, and regions for the breast lesion localization market.

Strategic Analysis: This includes M&A, new product development, and competitive landscape of the breast lesion localization market.

Analysis of competitive intensity of the industry based on Porter's Five Forces model.

FAQ

Q1. What is the breast lesion localization market size?

Answer: The global breast lesion localization market is expected to reach an estimated $453 million by 2030.

Q2. What is the growth forecast for breast lesion localization market?

Answer: The global breast lesion localization market is expected to grow with a CAGR of 7.1% from 2024 to 2030.

Q3. What are the major drivers influencing the growth of the breast lesion localization market?

Answer: The major drivers for this market are increased knowledge of early breast cancer detection, rise in the number of breast cancer surgeries, as well as, growing need for accurate and minimally invasive surgeries.

Q4. What are the major segments for breast lesion localization market?

Answer: The future of the global breast lesion localization market looks promising with opportunities in the hospital & clinic, diagnostic imaging center, and ambulatory surgical center markets.

Q5. Who are the key breast lesion localization market companies?

Answer: Some of the key breast lesion localization companies are as follows.

  • GE Healthcare
  • Dragerwerk
  • Koninklijke Philips
  • Ambu AS
  • Medline Industrie

Q6. Which breast lesion localization market segment will be the largest in future?

Answer: Lucintel forecasts that breast conservation is expected to witness the higher growth over the forecast period due to the increased detection of early-stage breast cancer and the trend toward less invasive methods.

Q7. In breast lesion localization market, which region is expected to be the largest in next 5 years?

Answer: APAC is expected to witness highest growth over the forecast period due to growing number of hospitals and rising healthcare expenditure, a large increase in patient volume, and a need for healthcare services.

Q.8 Do we receive customization in this report?

Answer: Yes, Lucintel provides 10% customization without any additional cost.

This report answers following 11 key questions:

  • Q.1. What are some of the most promising, high-growth opportunities for the breast lesion localization market by type (wire localization, radioisotope localization, magnetic localization, electromagnetic localization, and others), usage (breast biopsy and breast conservation), end use (hospitals & clinics, diagnostic imaging centers, ambulatory surgical centers, and others), and region (North America, Europe, Asia Pacific, and the Rest of the World)?
  • Q.2. Which segments will grow at a faster pace and why?
  • Q.3. Which region will grow at a faster pace and why?
  • Q.4. What are the key factors affecting market dynamics? What are the key challenges and business risks in this market?
  • Q.5. What are the business risks and competitive threats in this market?
  • Q.6. What are the emerging trends in this market and the reasons behind them?
  • Q.7. What are some of the changing demands of customers in the market?
  • Q.8. What are the new developments in the market? Which companies are leading these developments?
  • Q.9. Who are the major players in this market? What strategic initiatives are key players pursuing for business growth?
  • Q.10. What are some of the competing products in this market and how big of a threat do they pose for loss of market share by material or product substitution?
  • Q.11. What M&A activity has occurred in the last 5 years and what has its impact been on the industry?

Table of Contents

1. Executive Summary

2. Global Breast Lesion Localization Market : Market Dynamics

  • 2.1: Introduction, Background, and Classifications
  • 2.2: Supply Chain
  • 2.3: Industry Drivers and Challenges

3. Market Trends and Forecast Analysis from 2018 to 2030

  • 3.1. Macroeconomic Trends (2018-2023) and Forecast (2024-2030)
  • 3.2. Global Breast Lesion Localization Market Trends (2018-2023) and Forecast (2024-2030)
  • 3.3: Global Breast Lesion Localization Market by Type
    • 3.3.1: Wire Localization
    • 3.3.2: Radioisotope Localization
    • 3.3.3: Magnetic Localization
    • 3.3.4: Electromagnetic Localization
    • 3.3.5: Others
  • 3.4: Global Breast Lesion Localization Market by Usage
    • 3.4.1: Breast Biopsy
    • 3.4.2: Breast Conservation
  • 3.5: Global Breast Lesion Localization Market by End Use
    • 3.5.1: Hospitals & Clinics
    • 3.5.2: Diagnostic Imaging Centers
    • 3.5.3: Ambulatory Surgical Centers
    • 3.5.4: Others

4. Market Trends and Forecast Analysis by Region from 2018 to 2030

  • 4.1: Global Breast Lesion Localization Market by Region
  • 4.2: North American Breast Lesion Localization Market
    • 4.2.1: North American Breast Lesion Localization Market by Usage: Breast Biopsy and Breast Conservation
    • 4.2.2: North American Breast Lesion Localization Market by End Use: Hospitals & Clinics, Diagnostic Imaging Centers, Ambulatory Surgical Centers, and Others
  • 4.3: European Breast Lesion Localization Market
    • 4.3.1: European Breast Lesion Localization Market by Usage: Breast Biopsy and Breast Conservation
    • 4.3.2: European Breast Lesion Localization Market by End Use: Hospitals & Clinics, Diagnostic Imaging Centers, Ambulatory Surgical Centers, and Others
  • 4.4: APAC Breast Lesion Localization Market
    • 4.4.1: APAC Breast Lesion Localization Market by Usage: Breast Biopsy and Breast Conservation
    • 4.4.2: APAC Breast Lesion Localization Market by End Use: Hospitals & Clinics, Diagnostic Imaging Centers, Ambulatory Surgical Centers, and Others
  • 4.5: ROW Breast Lesion Localization Market
    • 4.5.1: ROW Breast Lesion Localization Market by Usage: Breast Biopsy and Breast Conservation
    • 4.5.2: ROW Breast Lesion Localization Market by End Use: Hospitals & Clinics, Diagnostic Imaging Centers, Ambulatory Surgical Centers, and Others

5. Competitor Analysis

  • 5.1: Product Portfolio Analysis
  • 5.2: Operational Integration
  • 5.3: Porter's Five Forces Analysis

6. Growth Opportunities and Strategic Analysis

  • 6.1: Growth Opportunity Analysis
    • 6.1.1: Growth Opportunities for the Global Breast Lesion Localization Market by Type
    • 6.1.2: Growth Opportunities for the Global Breast Lesion Localization Market by Usage
    • 6.1.3: Growth Opportunities for the Global Breast Lesion Localization Market by End Use
    • 6.1.4: Growth Opportunities for the Global Breast Lesion Localization Market by Region
  • 6.2: Emerging Trends in the Global Breast Lesion Localization Market
  • 6.3: Strategic Analysis
    • 6.3.1: New Product Development
    • 6.3.2: Capacity Expansion of the Global Breast Lesion Localization Market
    • 6.3.3: Mergers, Acquisitions, and Joint Ventures in the Global Breast Lesion Localization Market
    • 6.3.4: Certification and Licensing

7. Company Profiles of Leading Players

  • 7.1: GE Healthcare
  • 7.2: Dragerwerk
  • 7.3: Koninklijke Philips
  • 7.4: Ambu AS
  • 7.5: Medline Industrie